IMMUNE-MEDIATED HEPATITIS

Clinical trials for IMMUNE-MEDIATED HEPATITIS explained in plain language.

Never miss a new study

Get alerted when new IMMUNE-MEDIATED HEPATITIS trials appear

Sign up with your email to follow new studies for IMMUNE-MEDIATED HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1

New drug combo aims to tame liver side effects of cancer immunotherapy

Disease control Not yet recruiting

This study tests whether combining mycophenolate mofetil (MMF) with prednisone can better treat liver inflammation caused by checkpoint inhibitor cancer drugs. The trial includes adults with moderate to severe immune-related hepatitis who need to pause their cancer therapy. The m…

Matched conditions: IMMUNE-MEDIATED HEPATITIS

Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

IMMUNE-MEDIATED HEPATITIS

Get alerted when new IMMUNE-MEDIATED HEPATITIS trials appear

New drug combo aims to tame liver side effects of cancer immunotherapy